The Combination Very Low-Dose Naltrexone–Clonidine in the Management of Opioid Withdrawal
Authors:
- 10 January 2012
- journal article
- research article
- Published by Taylor & Francis in The American Journal of Drug and Alcohol Abuse
- Vol. 38 (3) , 200-205
Abstract
Background: The management of withdrawal absorbs substantial clinical efforts in opioid dependence (OD). The real challenge lies in improving current pharmacotherapies. Although widely used, clonidine causes problematic adverse effects and does not alleviate important symptoms of opioid withdrawal, alone or in combination with the opioid antagonist naltrexone. Very low-dose naltrexone (VLNTX) has been shown to attenuate withdrawal intensity and noradrenaline release following opioid agonist taper, suggesting a combination with clonidine may result in improved safety and efficacy. Objectives: We investigated the effects of a VLNTX–clonidine combination in a secondary analysis of data from a double-blind, randomized opioid detoxification trial. Methods: Withdrawal symptoms and treatment completion were compared following VLNTX (.125 or .25 mg/day) and clonidine (.1–.2 mg q6h) in 127 individuals with OD undergoing 6-day methadone inpatient taper at a community program. Results: VLNTX was more effective than placebo or clonidine in reducing symptoms and signs of withdrawal. The use of VLNTX in combination with clonidine was associated with attenuated subjective withdrawal compared with each medication alone, favoring detoxification completion in comparison with clonidine or naltrexone placebo. VLNTX/clonidine was effective in reducing symptoms that are both undertreated and well controlled with clonidine treatment and was not associated with significant adverse events compared with other treatments. Conclusions and Scientific Significance: Preliminary results elucidate neurobiological mechanisms of OD and support the utility of controlled studies on a novel VLNTX + low-dose clonidine combination for the management of opioid withdrawal.Keywords
This publication has 27 references indexed in Scilit:
- Transitioning opioid-dependent patients from detoxification to long-term treatment: Efficacy of intensive role inductionDrug and Alcohol Dependence, 2011
- Opioid antagonists with minimal sedation for opioid withdrawal2009
- Electrocardiographic Effects of Lofexidine and Methadone Coadministration: Secondary Findings from a Safety StudyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009
- Alpha2-adrenergic agonists for the management of opioid withdrawal2009
- CLINICAL STUDY: Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trialAddiction Biology, 2009
- Pathogenesis and Management of Postoperative IleusClinics in Colon and Rectal Surgery, 2009
- Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrainProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Conformational cross-talk between α2A-adrenergic and μ-opioid receptors controls cell signalingNature Chemical Biology, 2008
- Clonidine is not a Useful Adjunct to Methadone Gradual Detoxification in Opioid AddictionThe British Journal of Psychiatry, 1994
- CLONIDINE VERSUS METHADONE FOR OPIATE DETOXIFICATIONThe Lancet, 1980